OKEY STEPHANIE sold 18.4% of their position (3K shares) of CRINETICS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $119.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2026ACC: 0001628280-26-014775
Director
Since Jul 2019
-3K
Net shares
Net seller
$119.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$39.67
Trade value
$119.01K
% of position
18.4%
3/3/2026
16.30K→13.30K
Total
Net shares
−3K
Net value
-$119.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2026 | S · Sale | −3K | $39.67 | $119.01K | 18.4% | 16.30K | 13.30K |
| Total | −3K | -$119.01K | ||||||
Derivative Transactions0
No derivative transactions reported